U.S. Markets close in 28 mins
  • S&P 500

    4,541.01
    -25.99 (-0.57%)
     
  • Dow 30

    34,218.49
    -265.23 (-0.77%)
     
  • Nasdaq

    15,343.89
    -193.80 (-1.25%)
     
  • Russell 2000

    2,169.87
    -29.04 (-1.32%)
     
  • Crude Oil

    65.33
    -0.85 (-1.28%)
     
  • Gold

    1,781.30
    +4.80 (+0.27%)
     
  • Silver

    22.22
    -0.60 (-2.61%)
     
  • EUR/USD

    1.1316
    -0.0023 (-0.2037%)
     
  • 10-Yr Bond

    1.4340
    -0.0090 (-0.62%)
     
  • Vix

    28.26
    +1.07 (+3.94%)
     
  • GBP/USD

    1.3270
    -0.0032 (-0.2389%)
     
  • USD/JPY

    112.7880
    -0.3920 (-0.3463%)
     
  • BTC-USD

    56,978.36
    -406.64 (-0.71%)
     
  • CMC Crypto 200

    1,451.89
    -17.19 (-1.17%)
     
  • FTSE 100

    7,168.68
    +109.23 (+1.55%)
     
  • Nikkei 225

    27,935.62
    +113.86 (+0.41%)
     

4 Top Biotech Stocks to Watch as Economic Recovery Picks Up Pace

·1 min read

The biotech industry’s performance in the year so far has been decent as most of the bigwigs in the sector witnessed sales revival in the second quarter after a soft first quarter and provided an encouraging outlook for the remainder of the year. While the coronavirus treatments remain in focus, regulatory and pipeline developments are getting back on track with new drug approvals as the economic situation improves. Moderna MRNA and Regeneron REGN are leading the race when it comes to coronavirus treatments.

Vertex Pharmaceuticals VRTX and Horizon Therapeutics HZNP are also well poised on solid portfolio and pipeline progress.  



Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Regeneron Pharmaceuticals, Inc. (REGN) : Free Stock Analysis Report
 
Vertex Pharmaceuticals Incorporated (VRTX) : Free Stock Analysis Report
 
Moderna, Inc. (MRNA) : Free Stock Analysis Report
 
Horizon Therapeutics Public Limited Company (HZNP) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research